Mogamulizumab

Results: 2



#Item
1Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (NEW YORK and TOKYO, July 29, Kyowa Ha

Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S. (NEW YORK and TOKYO, July 29, Kyowa Ha

Add to Reading List

Source URL: www.kyowa-kirin.com

Language: English - Date: 2015-07-29 19:00:03
    2Immune system / Medicine / Monoclonal antibodies / Crucell / Biologic / Polyclonal antibodies / Cambridge Antibody Technology / Mogamulizumab / Biology / Immunology / Biotechnology

    Press Release: Bioceros - through its affiliated company BiocerOX Products and Janssen execute agreement to develop a monoclonal antibody. Utrecht, The Netherlands, January 8, 2014 Dutch Biotech company Bioceros today an

    Add to Reading List

    Source URL: www.bioceros.com

    Language: English - Date: 2014-01-08 02:14:10